Herein we report a case of a patient with metastatic HCC and large disease burden who was serendipitously found to have a very high ERBB2 copy number amplification by circulating tumor DNA (ctDNA) liquid biopsy, prompting us to perform confirmational testing and act on this actionable marker. Here, ERBB2 is linked to hepatocellular carcinoma.